These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9377846)
1. [Current aspects of therapy of primary biliary cirrhosis]. Grassi M; Manzi P; Schiffino L; Raffa S Clin Ter; 1997 Mar; 148(3):95-104. PubMed ID: 9377846 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate. Lee YM; Kaplan MM Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960 [TBL] [Abstract][Full Text] [Related]
7. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients]. Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654 [TBL] [Abstract][Full Text] [Related]
8. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236 [TBL] [Abstract][Full Text] [Related]
13. [Therapy of liver cirrhosis]. Paumgartner G Z Gastroenterol Verh; 1983 Apr; 18():63-9. PubMed ID: 6192610 [No Abstract] [Full Text] [Related]
14. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267 [TBL] [Abstract][Full Text] [Related]
15. A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis. Baruch Y; Assy N; Weisbruch F; Reisner SA; Rinkevich D; Enat R; Blendis LM; Bomzon A Am J Gastroenterol; 1999 Oct; 94(10):3000-4. PubMed ID: 10520859 [TBL] [Abstract][Full Text] [Related]
16. [What is safe in therapy of primary biliary cirrhosis?]. Wiedmann KH; Weber P; Lauchart W Internist (Berl); 1988 Nov; 29(11):765-77. PubMed ID: 3069789 [No Abstract] [Full Text] [Related]
17. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Angulo P; Jorgensen RA; Keach JC; Dickson ER; Smith C; Lindor KD Hepatology; 2000 Feb; 31(2):318-23. PubMed ID: 10655252 [TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003 [TBL] [Abstract][Full Text] [Related]
19. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. Lazaridis KN; Talwalkar JA J Clin Gastroenterol; 2007; 41(5):494-500. PubMed ID: 17450033 [TBL] [Abstract][Full Text] [Related]